The Milken Institute Middle East and Africa Summit brings together a mix of people you don’t usually see in one room. Investors, government officials, founders, and healthcare leaders. Different backgrounds, but often dealing with the same long-term questions.
In 2023, Sergey Young, an investor, was on the speaker list. The summit took place in Abu Dhabi under the theme Navigating Complexity through Collaboration, with 220 speakers focused on how different industries respond to shared challenges.
Why Global Investment Forums Are Paying More Attention to Longevity
A decade ago, longevity didn’t come up at investment conferences. It stayed mostly within research and healthcare. That’s no longer the case. The topic now shows up in a wider set of discussions. Governments look at aging populations and long-term spending. Investors treat longevity as a growing sector. For companies, it ties into workforce planning and productivity.
Because of that, the conversation moved. It left the lab and started appearing at the same forums where people talk about capital, policy, and economic growth. Sergey Young’s work sits in that space. He focuses on longevity as an investor, but also supports projects that bring the subject into a broader public and business context.
Sergey Young’s Biography: How an Investor Became Part of the Middle East Conversation
In 2023, Sergey Young appeared on the speaker list for the Milken Institute Middle East and Africa Summit in Abu Dhabi. By then, he had spent several years focused on longevity, not only through investing.
The Longevity Vision Fund was one part of it. He later joined BOLD Capital Partners, supported XPRIZE Healthspan, worked on Longevity@Work, and wrote The Science and Technology of Growing Young. Different formats, but the same direction — bringing longevity out of research and into a wider public conversation.
Why Abu Dhabi Has Become a Hub for Innovation and Long-Term Investment
Over the past few years, the city has been steadily building that role. Money plays a part, but so does focus. There’s been consistent investment in healthcare, technology, and research, often at the same time rather than in isolation.
You can see it in the mix of topics that come up at major events. AI, biotech, energy, finance. Different fields, but they keep overlapping. Longevity ends up in that mix almost by default as it touches medicine, but also raises questions about how people work, how long they stay in the workforce, and how countries plan ahead.
That’s why discussions about healthy aging don’t feel out of place at investment forums anymore. They sit next to conversations about long-term growth and infrastructure. Same audience, same concerns, just coming from a different angle. The Milken Institute summit works in that way. People from different backgrounds show up, talk through their own problems, and often realize they’re dealing with the same ones.
The whole of Sergey Young’s biography and work fit in without much explanation. His projects tend to connect research, capital, and public understanding, which is exactly the kind of overlap these forums are built around.
Sergey Young: an Investor Who Shows a Broader International Role
Before becoming closely associated with longevity, Young built a career in technology investing. He later founded Longevity Vision Fund and became a partner at BOLD Capital Partners, while also supporting educational and nonprofit initiatives such as XPRIZE Healthspan and Longevity@Work. Together, these projects reflect a consistent focus on helping scientific advances move beyond research and into everyday life.
Sergey Young’s work in longevity extends beyond investing. Over time, it has taken shape across several directions, from venture funding to public initiatives and education.
What stands out is where his projects land. They embrace business, policy, and workplace discussions. Longevity stops being something only scientists talk about and starts appearing in conversations about hiring, productivity, and long-term planning.
That shift also explains why Sergey Young’s biography is linked to public conversation, and why he keeps showing up at international forums. The topic itself moved there first. His work simply followed the same path, linking research with the people who decide how it gets used.
A Sign of Longevity’s Growing Global Importance
Sergey Young’s name on the Milken Institute MEA Summit speaker list says something about where the conversation has moved. A few years ago, longevity mostly came up in scientific and medical settings. Now it appears at the same forums where people talk about investment, technology, and economic policy.
That change is hard to miss. Longer lives raise questions that go well beyond healthcare, from workforce planning to public spending and long-term growth. Those topics already sit at the center of international business discussions.
The Abu Dhabi summit is one of the places where those threads meet. Longevity is no longer a separate track. It shows up alongside the issues that shape how economies develop and how companies plan for the future.
